Flagship Biosciences, Inc. — Form D/A

Flagship Biosciences, Inc. of BROOMFIELD, CO, a company, filed a Form D amendment with the SEC on 2024-02-21. The offering totals $5.0M, of which $3.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
William SniderDirectorBethesda, MD
Paul KirchgraberDirectorBroomfield, CO
Trevor JohnsonDirectorBroomfield, CO
Trevor JohnsonExecutive OfficerBroomfield, CO
Trevor JohnsonPromoterBroomfield, CO
Tom TuriDirectorBroomfield, CO
Tom TuriExecutive OfficerBroomfield, CO
Herb HooperDirectorBroomfield, CO
Bill H SniderDirectorBroomfield, CO
Fisher AaronDirectorBroomfield, CO
Herb H HooperDirectorBroomfield, CO
Tom H TuriDirectorBroomfield, CO
Joe Dean KrugerExecutive OfficerWestminster, CO
Nancy Dean GillettDirectorWestminster, CO
G. David YoungDirectorWestminster, CO
G. David YoungExecutive OfficerWestminster, CO
G. David YoungPromoterWestminster, CO
Gary Dean ClarkDirectorWestminster, CO
L. Dean NortheyExecutive OfficerWestminster, CO
Holger Dean LangeExecutive OfficerWestminster, CO
Dean David NortheyExecutive OfficerWestminster, CO
Nancy A GillettDirectorWestminster, CO
Gary M ClarkDirectorWestminster, CO
Gregory K TuckerDirectorWestminster, CO

Other filings by this issuer (5)

FiledFormOfferingSold
2024-04-18D$6.4M$5.0M
2023-12-14D$1.5M$1.5M
2022-09-09D$15.3M$15.3M
2018-07-09D$2.5M$2.5M
2018-03-16D$1.0M$1.0M

More